Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients (SARMETA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01657214
Recruitment Status : Completed
First Posted : August 6, 2012
Last Update Posted : February 17, 2016
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2016
  Study Completion Date : January 2016